| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000032941 |
| Receipt No. | R000037549 |
| Scientific Title | Validation of a new tele-monitoring modality (TeleOX) in patients with interstitial pneumonias |
| Date of disclosure of the study information | 2018/06/11 |
| Last modified on | 2020/12/13 (Ver. 5) |
| Basic information | ||
| Public title | Validation of a new tele-monitoring modality (TeleOX) in patients with
interstitial pneumonias |
|
| Acronym | Validation of the performance of
TeleOX |
|
| Scientific Title | Validation of a new tele-monitoring modality (TeleOX) in patients with
interstitial pneumonias |
|
| Scientific Title:Acronym | Validation of the performance of
TeleOX |
|
| Region |
|
|
| Condition | ||
| Condition | Interstitial pneumonia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine the accuracy of respiratory rate measurement by TeleOX during wakefulness and sleep in patients with interstitial pneumonias |
| Basic objectives2 | Others |
| Basic objectives -Others | To analyze the correlation between the respiratory rate measured by TeleOX and that measured polysomnography |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Correlation of the respiratory rate measured by TeleOX and that measured by polysomnography during wakefulness and sleep |
| Key secondary outcomes | 1.Prevalence and severity of sleep related breathing disorders and sleep quality evaluated by questionnaires, including Pittsburg Sleep Quality Index, Japanese version of Epworth Sleepiness Scale, and Japanese version of the Athens Insomnia Scale, in patients with interstitial pneumonias
2.Changes of respiratory rate and percutaneous carbon dioxide partial pressure by oxygen administration 3.Correlation of clinical characteristics and quality of life evaluated by questionnaires, including modified MRC dyspnea scale, Hospital Anxiety and Depression Scale, Idiopathic pulmonary fibrosis-St.Geroge's Respiratory Questionnaire, and Short-Form 36 4.Correlation of percutaneous oxygen saturation and percutaneous carbon dioxide partial pressure and pulmonary arterial pressure measured by transthoracic echocardiography 5.Correlation between clinical characteristics and physical activity evaluated by Actiwatch |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Male or female patients aged 20-85 years
2.Treatment drugs do not matter. 3.Patients with interstitial pneumonias followed at the Department of Respiratory Medicine in Kyoto University Hospital 4.Patients with suspected sleep-related breathing disorders by the examination with pulse-oximeter (PULSOX-300i) or Watch-PAT in the setting of outpatient clinic |
|||
| Key exclusion criteria | 1.Patients are excluded if they are in active phase of acute exacerbation of interstitial pneumonia or respiratory infections; new onset pneumothorax or exacerbation of chronic pneumothorax; or unstable state due to the worsening of other comorbidities (e.g. heart failure, bronchial asthma, and renal failure).
2.Patients are excluded if they are already treated with nasal continuous positive airway pressure therapy for obstructive sleep apnea syndrome. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Graduate School of Medicine, Kyoto University | ||||||
| Division name | Department of Advanced Medicine for Respiratory Failure | ||||||
| Zip code | 606-8507 | ||||||
| Address | 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto | ||||||
| TEL | 075-366-7689 | ||||||
| hanta@kuhp.kyoto-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Graduate School of Medicine, Kyoto University | ||||||
| Division name | Department of Advanced Medicine for Respiratory Failure | ||||||
| Zip code | 606-8507 | ||||||
| Address | 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto | ||||||
| TEL | 075-366-7689 | ||||||
| Homepage URL | |||||||
| hanta@kuhp.kyoto-u.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Advanced Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | TEIJIN PHARMA |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kyoto University Graduate School and Faculty of Medicine Kyoto University Hospital Ethics Committe |
| Address | Yoshida Konoe-cho, Sakyo-ku, Kyoto |
| Tel | 075-753-4680 |
| ethcom@kuhp.kyoto-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 京都大学医学部附属病院(京都府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 19 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | This study is a prospective observational study in patients with interstitial pneumonia. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000037549 |